New laser combo shows promise for rosacea redness

NCT ID NCT07250165

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a combination of two lasers (KTP and Nd:YAG) to treat persistent facial redness in 15 adults with rosacea. Each person received three treatments, three weeks apart. The goal was to see if the lasers could safely reduce redness and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
532 nm KTP laser and microsecond 1064 nm Nd:YAG laser
What this could lead to
If successful, this laser combination could provide a safe, non-drug option to reduce persistent facial redness in rosacea patients.
What could go wrong
This was a very small study (15 people) with no comparison group, so results may not apply to everyone. Long-term safety and effectiveness are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ROSACEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Second Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, None Selected, 310009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.